ARCADIA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.09 USD | +9.99% |
|
+1.46% | -33.23% |
| 28/03 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 28/03 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
| Sales 2024 * | 6.22M 519M | Sales 2025 * | 8M 667M | Capitalization | 2.85M 237M |
|---|---|---|---|---|---|
| Net income 2024 * | -10M -834M | Net income 2025 * | -8M -667M | EV / Sales 2024 * | 0.46 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.36 x |
| P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-0.45
x | Employees | 21 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Arcadia Biosciences, Inc.
More recommendations
More press releases
| 1 day | +9.99% | ||
| 1 week | +1.46% | ||
| Current month | -5.43% | ||
| 1 month | -10.38% | ||
| 3 months | -17.72% | ||
| 6 months | -46.27% | ||
| Current year | -33.23% |
1 week
1.90
2.19
1 month
1.852.30
Current year
1.853.11
1 year
1.857.30
3 years
1.85130.00
5 years
1.85408.00
10 years
1.857 040.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stanley Jacot
CEO | Chief Executive Officer | 54 | 02/22/02 |
Thomas Schaefer
DFI | Director of Finance/CFO | 48 | 01/20/01 |
Kevin Comcowich
CHM | Chairman | 55 | 01/16/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Amy Yoder
BRD | Director/Board Member | 56 | 10/17/10 |
Gregory Waller
BRD | Director/Board Member | 74 | 13/17/13 |
Kevin Comcowich
CHM | Chairman | 55 | 01/16/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 2.09 | +9.99% | 9,574 |
| 25/24/25 | 1.9 | -7.76% | 2,915 |
| 24/24/24 | 2.06 | +1.47% | 19,797 |
| 23/24/23 | 2.03 | -4.24% | 6,783 |
| 22/24/22 | 2.12 | +2.91% | 65,795 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes
Arcadia Biosciences, Inc. is a producer and marketer of plant-based food and beverage products. The Company is engaged in developing crop improvements, primarily in wheat, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. The Company is using non-genetically modified (non-GMO) advanced breeding techniques to develop products. Its product portfolio includes GoodWheat Pasta, GoodWheat Pancakes and Waffle Mixes, GoodWheat Mac and Cheese, Zola Coconut Water, and GoodWheat Wheat Traits. Its GoodWheat pasta has five varieties of penne, spaghetti, fettuccine, elbows, and rotini. Its GoodWheat pancake and waffle mixes are sold in resealable, multi-serve pouches, and mixes are available in three varieties, including buttermilk, chocolate chip and apple cinnamon. It operates under Saavy Naturals, Soul Spring, and ProVault brands. ProVault, is a THC-free CBD sports performance formula made with natural ingredients.
Sector
Agricultural Chemicals
Calendar
10/05/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.09
USD
Average target price
11
USD
Spread / Average Target
+426.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -33.23% | 2.85M | |
| +14.61% | 38.38B | |
| -.--% | 11.15B | |
| -7.28% | 7.3B | |
| +7.47% | 6.87B | |
| -3.91% | 5.91B | |
| -10.44% | 5.6B | |
| -6.14% | 5.54B | |
| +31.35% | 5.19B | |
| -13.45% | 4.58B |
- Stock Market
- Equities
- RKDA Stock
